Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

MabThera/Rituxan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.

CTI slumps as Servier-partnered lymphoma drug fails

CTI slumps as Servier-partnered lymphoma drug fails The PIX306 trial paired Pixuvri (pixantrone) – already sold in some European markets as a monotherapy for hard-to-treat NHL – with Roche’s MabThera (rituximab) and compared it to MabThera plus

AbbVie, Roche get FDA OK for broader use of Venclexta

AbbVie, Roche get FDA OK for broader use of Venclexta now also be used in patients without that mutation, both alone and in combination with Rituxan. ... A similar marketing application is under review by the EMA. In MURANO, giving first-in-class BCL-2-targeting drug Venclexta (venetoclax) with anti-CD20

Roche’s MabThera ends drug drought for serious skin disease

Roche’s MabThera ends drug drought for serious skin disease Roche’s ageing blockbuster MabThera has picked up a new approval in life-threatening skin disorder pemphigus vulgaris, becoming the first new treatment for the disease in six decades. ... MabThera (rituximab) – an anti-CD20 antibody known as Rituxan

Ocrevus helps Roche stave off biosimilar threat

Ocrevus helps Roche stave off biosimilar threat The third of the big three - Mabthera/Rituxan (rituximab) - did not fare as well as its peers however, with sales down 8% to CHF 1.7bn overall and plummeting 44% in

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more from blockbusters Avastin, Herceptin and Mabthera/Rituxan.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics